Zai Lab (ZLAB) EBIT Growth (5y) (2023 - 2026)

Zai Lab (ZLAB) EBIT Growth (5y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Zai Lab 2.91 Bn 2.20 Bn 58.15 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 14.82%
Mar 31, 2026 21.11%
Dec 31, 2025 6.14%
Sep 30, 2025 8.53%
Jun 30, 2025 8.15%
Mar 31, 2025 -3.98%
Dec 31, 2024 -5.46%
Sep 30, 2024 -0.78%
Dec 31, 2023 -13.25%